Abstract: Treatment of chronic fatigue syndrome by dietary supplementation with omega-3 fatty acids

Journal: Med Hypotheses 2002 Mar;58(3):249-50

Authors: Tamizi far B, Tamizi B.

Affiliation: Department of Research, Isfahan University of Medical Sciences, Isfahan, Iran

NLM Citation: PMID: 12018979

Minor alterations of immune, neuroendocrine, and autonomic function may be associated with the chronic fatigue syndrome.

Omega-3 fatty acids decrease the production of putative mediators of inflammation, including interleukin-1, and tumor necrosis factor.

Since interleukin-1 and tumor necrosis factor are the principal polypeptide mediators of immunoregulation, reduced production of these cytokines by dietary supplementation with omega-3, may be a possible mechanism for the treatment of chronic fatigue syndrome.

Copyright 2002, Elsevier Science Ltd. All rights reserved.

1 Star2 Stars3 Stars4 Stars5 Stars (143 votes, average: 2.95 out of 5)

Leave a Reply